Cost-Effectiveness of Hepatitis C Treatment for Patients in Early Stages of Liver Disease

Details

• Alternative Title:
  Hepatology
• Personal Author:
  Leidner, Andrew J. ; Chesson, Harrell W. ; Xu, Fujie ; Ward, John W. ; Spradling, Philip R. ; Holmberg, Scott D.
• Description:
  Conclusion
  
  Immediate treatment of HCV-infected patients with moderate and advanced fibrosis appears to be cost-effective, and immediate treatment of patients with minimal or no fibrosis can be cost-effective as well, particularly when lower treatment costs are assumed.
  
  
• Subjects:
  Antiviral Agents Article Cost-Benefit Analysis Hepatitis C Humans Models, Economic
• Source:
  Hepatology. 61(6):1860-1869.
• Pubmed ID:
  25677072
• Pubmed Central ID:
  PMC5802336
• Document Type:
  Journal Article
• Funding:
  CC999999/Intramural CDC HHS/United States
• Volume:
  61
• Issue:
  6
• Collection(s):
  CDC Public Access
• Main Document Checksum:
  urn:sha256:37edca4ce02dcaa459792ea8bc203e2c4c4ae3fcfeeacd8c5637f075995ecb5c
• Download URL:
  https://stacks.cdc.gov/view/cdc/51516/cdc_51516_DS1.pdf
• File Type:
  [PDF - 763.09 KB ]